Does hyaluronidase dissolve biostimulators? Myth or fact
Quick facts
- Short answer
- In general, myth. The enzyme acts on hyaluronic acid, not on biostimulators.
- Exception to check
- Products combined with hyaluronic acid, where only that fraction responds to the enzyme.
- If there is a nodule
- Individual assessment, with approaches different from those used for filler.
- Before injecting
- Explain that, with a biostimulator, there is no undo button.
The question usually comes from a mix-up: the patient has heard about "that enzyme that dissolves filler" and asks whether it also fixes a biostimulator that left a mark. The answer, broadly, is no. Hyaluronidase has a single target, hyaluronic acid, and collagen biostimulators are made of other substances.
This text is for you to align expectations before the first injection and to know how to proceed when a patient arrives with an irregularity in the area of a biostimulator.
Why doesn't the enzyme act on a biostimulator?
The best-known biostimulators have a chemical nature different from hyaluronic acid gel. Calcium hydroxylapatite is a mineral in microspheres suspended in a gel; polylactic acid and polycaprolactone are polymers the body breaks down slowly. None of them has the molecule that hyaluronidase breaks.
This changes the risk conversation. With hyaluronic filler, there is a reversal resource. With a biostimulator, there is no simple equivalent, and the effect tends to fade on its own over months, as the product is metabolized. That is why planning and technique need to be conservative, and the patient needs to understand this difference before signing the consent form.
| Product | Hyaluronidase target | What usually happens over time |
|---|---|---|
| Hyaluronic acid filler | Yes | Gradual breakdown, or earlier with the enzyme |
| Calcium hydroxylapatite | No | Matrix resorption and collagen stimulation, over months |
| Polylactic acid | No | Slow breakdown, with an effect built up over sessions |
| Polycaprolactone | No | Slow breakdown, over a long period |
| Hybrid product with hyaluronic acid | Only the hyaluronic fraction | Depends on the composition, check the package insert |
What to do when an irregularity or nodule appears?
A nodule after a biostimulator can be persistent swelling, product accumulation, an inflammatory reaction or, more rarely, a granuloma. The time since the injection, pain, warmth and redness help to tell them apart. Broadly, the approach is to observe what is recent, avoid manipulation, and reassess with standardized photos and palpation.
If it is a recent nodule without inflammatory signs, observation is often the approach. Persistence, pain or signs of infection call for an in-person assessment and may require specific treatment, which varies by case and must be decided by a qualified professional. The page biostimulator: nodules covers the topic in depth.
The confusing exception: combining products
Many clinics combine a biostimulator and filler in the same area, in different sessions or in the same one. If there is an irregularity, the first question is which product causes what. The enzyme can reduce the hyaluronic part and the irregularity may still persist, because the biostimulator stayed where it is. That is why, when combining, record what was injected, where and when, instead of relying on memory. The reasoning for combining is in biostimulator and filler on the same day.
Why this difference weighs on consent
A patient who understands that a biostimulator has no undo button decides more calmly, accepts spaced-out sessions and values the initial assessment. This is part of informed consent: risks, alternatives and the limits of reversal in writing. For the patient who wants to compare with filler, the logic is in biostimulator or filler.
What about vascular risk?
Biostimulators can also, rarely, cause vascular problems, and hyaluronidase is not their treatment. The text vascular occlusion from a biostimulator covers the signs and the approach, which are different from those used with hyaluronic acid. The patient should know the warning signs of any injection: intense and growing pain, pale skin or skin with net-like blotches, and any change in vision call for immediate contact.
Frequently asked questions
Does hyaluronidase dissolve collagen biostimulators?
In general, no. Calcium hydroxylapatite, polylactic acid and polycaprolactone have a different composition from hyaluronic acid and are not broken down by the enzyme.
If the biostimulator left a nodule, what should be done?
It depends on the type of product, the time elapsed and the associated signs. The professional assesses, and may observe, advise on care or refer. No massage or puncture is done without guidance.
Is there a biostimulator the enzyme acts on?
There are products that combine a biostimulator with hyaluronic acid. The enzyme may reduce the hyaluronic part, but not the biostimulator fraction. Check the composition in the package insert.
Then why does hyaluronidase appear on biostimulator pages?
Because a clinic that injects hyaluronic products in the same session or in nearby sessions needs it available. It is the resource for the gel, not for the biostimulator.
Harmy images are illustrative simulations generated by AI from the patient's photo to support the conversation between practitioner and patient. They are not a promise of results. Indication, technique, product and volume are solely the decision of the licensed practitioner. This content is for information only and does not replace a clinical assessment.